Suicide is a complex public health problem of global importance. Suicidal behaviour diff ers between sexes, age groups, geographic regions, and sociopolitical settings, and variably associates with diff erent risk factors, suggesting aetiological heterogeneity. Although there is no eff ective algorithm to predict suicide in clinical practice, improved recognition and understanding of clinical, psychological, sociological, and biological factors might help the detection of high-risk individuals and assist in treatment selection. Psychotherapeutic, pharmacological, or neuromodulatory treatments of mental disorders can often prevent suicidal behaviour; additionally, regular follow-up of people who attempt suicide by mental health services is key to prevent future suicidal behaviour.
Introduction
Suicide takes a staggering toll on global public health, with almost 1 million people dying from suicide worldwide each year. 1 WHO has declared that reducing suicide-related mortality is a global imperative, a welcome contrast to the traditional taboo that has surrounded suicidal behaviours. Cultural and moral beliefs about suicide, and unnecessarily pessimistic views about treatment and prevention of suicide, are barriers to patient self-disclosure and clinicians' routine inquiries about suicidal thoughts. About 45% of people who die by suicide consult a primary care physician within 1 month of death, yet documentation of physician inquiry or patient disclosure is rare. 2 We review the epidemiology, risk factors, and eff ective interventions in primary care and specialty mental health facilities aimed at the prevention or treatment of suicidal behaviour.
Defi nitions and assessment
Clear discussion, accurate research, and effi cient treatment require accepted defi nitions of suicidal behaviours. The diffi culty of establishing intent of self-harming behaviours has hindered eff orts to streamline the historically heterogeneous suicide nomenclature, but eff orts, such as those resulting in the Columbia Classifi cation Algorithm of Suicide Assessment, 3 have contributed to standardising nomenclature (table). The severity of suicidal behaviour varies, on the basis of family studies showing the progression from less to more severe forms of suicidal ideation and behaviour, and from family and biological studies showing overlap between attempted and completed suicide. 4 
Epidemiology
Precise global estimates of suicide rates are diffi cult to obtain, as only 35% of WHO member states have comprehensive vital registration with at least 5 years of data. 1 Globally, an estimated 11·4 suicides per 100 000 people occur per year, resulting in 804 000 deaths. 1 Suicide rates vary within and b etween countries, with as much as a ten-times diff erence between regions; this variation is partly correlated with economic status and cultural diff erences. 1 Cultural infl uences might trump geographic location, because the suicide rates of immigrants are more closely correlated with their country of origin than with their adoptive country. 5 Indigenous peoples have high rates of suicide, 6 which might be caused by disruption of traditional cultural and family supports, lower socioeconomic status, and increased prevalence of alcohol and substance use, which are also risk factors for suicide in the general population. 6 Non-fatal suicidal behaviours are more common than suicides. 7, 8 Data from 108 705 people included in the WHO World Mental Health Survey 8 suggest that the average 12-month prevalence of ideation is 2·0% in high-income countries versus 2·1% in low-income countries, and the prevalence of suicide attempts is 0·3% versus 0·4%. The worldwide lifetime prevalence of ideation is 9·2% and that of attempts is 2·7%, 9 but rates of ideation and suicidal behaviour vary greatly between countries (fi gure 1). 1, [9] [10] [11] [12] Individuals who report suicide ideation within the previous 12 months have signifi cantly higher 12-month prevalence rates of suicide attempts (15·1% in high-income countries and 20·2% in low-income countries), and suicidal planning further increases risk. 7, 8 Roughly a third of adolescents with suicide ideation will go on to attempt suicide within 1 year, 7 and people who attempt suicide presenting to an emergency department have a 12-month risk of suicide of 1·6% and of repeated suicide attempt of 16·3%, with a 5-year risk of suicide of 3·9%. 13 In high-income countries, suicide is most common among middle-aged and elderly men. 1 However, rates of suicide in young people are increasing, and suicide is the second leading cause of death in individuals aged 15-29 years. 1 The incidence of suicide ideation and suicidal behaviour peaks in adolescents and young adults, with a lifetime prevalence of suicidal ideation of 12·1-33%, and of suicidal behaviour of 4·1-9·3%. 7, 14 In elderly people, rates of suicidality are also high, particularly among those with physical disorders, depression, and anxiety. 15 Sex is also a factor in suicidal behaviour, with higher rates of ideation and suicide attempts among women; 8, 9 however, rates of suicide deaths are generally higher in men (15 per 100 000 men vs eight per 100 000 women, worldwide). 1 The ratio of
Defi nition Comments
Suicide A fatal self-injurious act with some evidence of intent to die ·· Suicide attempt A potentially self-injurious behaviour associated with at least some intent to die Some younger people who attempt suicide report that their main motivation is other than to die, such as to escape an intolerable situation, to express hostility, or to get attention; however, many nonetheless acknowledge the possibility that their behaviour could have resulted in death; suicide attempt is characterised by greater functional impairment than non-suicidal self-injury Active suicide ideation Thoughts about taking action to end one's life, including identifying a method, having a plan, or having intent to act
Highly specifi c ideation, such as having made a plan or having intent, is associated with a much greater risk of a suicide attempt within 12 months
Passive suicide ideation Thoughts about death or wanting to be dead without any plan or intent ·· Non-suicidal self-injury Self-injurious behaviour with no intent to die Diff ers from suicide attempt in terms of motivation, familial transmission (found only in suicidal behaviour), age of onset (younger in non-suicidal self-injury), psychopathology, and functional impairment (greater in suicide attempt); non-suicidal self-injury most commonly consists of repetitive cutting, rubbing, burning, or picking; the main motivations are either to relieve distress, to "feel something", to induce self-punishment, to get attention, or to escape a diffi cult situation
Suicidal events
The onset or worsening of suicide ideation or a suicide attempt, an emergency referral for ideation, or suicidal behaviour
Often used as an endpoint in pharmacological studies; rescue procedures are included in this category because a patient with ideation who then received emergency intervention might have made an attempt had he or she not been recognised and treated
Preparatory acts toward imminent suicidal behaviours ·· ··
Deliberate self-harm Any type of self-injurious behaviour, including suicide attempts and non-suicidal self-injury
The combination of suicide attempts and non-suicidal self-injury into one category refl ects their high comorbidity, shared diathesis, and the fact that non-suicidal self-injury is a strong predictor of eventual suicide attempt; not all events classifi ed as a suicide attempt are motivated by a true desire to die, but rather by desires to attract attention, to escape, and to communicate hostility; however, when only deliberate self-harm is reported, suicide attempts and non-suicidal self-injury cannot be subsequently disaggregated Table: Nomenclature for suicidal and related behaviours and suicidal ideation F r a n c e 1 0 G e r m a n y 1 0 I t a ly 1 0 N e t h e r la n d s 1 0 S p a i n 1 0 U k r a i n e 1 0 I s r a e l 1 0 L e b a n o n 1 0 N i g e r i a 1 0 S o u t h A f r i c a 1 0 A u s t r a li a 1 2 N e w Z e a la n d 1 0 C h i n a 1 0 J a p a n 1 0 S o u t h K o r e a 1 3 Suicide deaths Prevalence of non-fatal suicidal behaviour per 100 people male to female deaths by suicide is higher in high-income countries (3·5) than in low-to-middle-income countries (1·6), and in Europe and the Americas (3·6-4·1) than in Asian Pacifi c countries (0·9-1·6). 1 Seasonal variation in suicide rates has also been reported, with peak incidence in spring and summer, and suicide rates might correlate with latitude and exposure to sunshine. 16 
Suicidal ideation

Contemporary models of suicide risk
In the past century, the contributions of both social and individual factors to understanding suicide risk have been recognised. Several models have been proposed, most emphasising the interaction between predisposing and precipitating factors. [17] [18] [19] [20] Figure 2 shows putative temporal relationships between diff erent suicide risk factors. Suicide has many causes, with substantial variability in the strengths and patterns of association of risk factors across sex, age, culture, geographic location, and personal history. Thus, models have been proposed to explain risks of suicide in specifi c subgroups, such as in people exposed to early-life adversity. 21, 22 Factors and associated mechanisms that increase risk of suicide
Population-level risk factors
More than a century ago, Durkheim recognised the eff ect of population-level social factors on suicide rates. Increases in suicide rates among indigenous peoples, such as Canadian Inuits, correlate with social changes such as forced settlement, assimilation, and disruption of traditional social structure. 6 Conversely, suicide is rare in homogeneous societies with high social cohesion, common values, and moral objections to suicide, 23, 24 although the latter might also lead to under-reporting. Economic crises resulting in unemployment and decreased personal income have been correlated with increases in suicide, particularly in men, although a direct causal relationship has not yet been established. 25, 26 Media reporting of suicide also aff ects suicide rates, particularly within the fi rst 30 days of publicity, with increases in the rate of suicide proportional to the amount of publicity, when details of a method are provided, if the decedent was a celebrity, and if the Model for suicide risk Suicide risk is modulated by a range of factors both at the population and individual levels. Individual risk factors can be grouped into distal (or predisposing), developmental (or mediating), and proximal (or precipitating) factors, and many of these factors interact to contribute to the risk of developing suicidal behaviours. *Any single mental illness associated with suicide risk, or a combination of mental illnesses, including major depressive disorder, bipolar disorder, schizophrenia, and personality disorders; the presence of a depressive episode is often a sign of increased risk of suicide. 4, 29, 30 indicating that distal factors can increase suicide risk. Family studies show that the risk of attempts is higher in relatives of people who died by suicide, and that the risk of dying by suicide is higher in relatives of people with a history of suicide attempts. 31 These eff ects are unlikely to result from imitation because adoption studies show concordance between biological, but not adoptive relatives. 32 Although psychopathological disorders also aggregate in families, the transmission of suicidal behaviour seems to be mediated through the transmission of impulsive aggression. 4, 33 Twin and adoption studies suggest that genetic factors account for part of the familial transmission of suicidal behaviour, with estimates of heritability of 30-50%. 34, 35 However, when the heritability of other psychiatric conditions is taken into account, the specifi c heritability of suicidality is estimated as 17·4% for suicide attempts and 36% for suicide ideation. 35 Ideation seems to be cotransmitted with mood disorders and shows a distinct pattern for transmission from suicidal behaviour. 4, 36 Despite consistent evidence for the heritability of suicidal behaviour, the identifi cation of specifi c genes associated with suicide risk remains elusive, despite several candidate-gene and genome-wide association studies, which have mostly provided inconclusive results. 21 Modelling the interactions between experience and genes would be useful.
In addition to heritable factors, other psychosocial, demographic, and biological factors increase vulnerability to suicide. 17 Sexual orientation aff ects suicide risk, and although psychological autopsy-based studies of completed suicides have not consistently shown an over-representation of sexual minority status in people who die by suicide, analysis of registry-based data suggests that individuals with a history of same-sex relationships have a 3-4-times greater risk of dying by suicide, with a disproportionately greater risk for men than for women. Belonging to a sexual minority is universally linked with increased rates of suicide attempts irrespective of sex. 37 Another well characterised risk factor is exposure to early-life adversity, generally defi ned as parental neglect or childhood physical, sexual, or emotional abuse. The association between early-life adversity and lifetime suicide risk is supported by evidence from prospective 38, 39 and retrospective longitudinal studies, 40 as well as multiple case-control studies, 22 and is moderated by several factors, including the type of abuse (neglect, physical abuse, or sexual abuse), the frequency of the abuse, and the relationship between the victim and the abuser. 39 Early-life adversity might also be transmitted through families, partly explaining the familial aggregation of suicidal behaviour. 41 Early-life adversity might induce long-term eff ects through epigenetic changes in gene pathways. The hypothalamicpituitary-adrenal axis regulates physiological responses to stress to facilitate coping with changing environments or challenging events, mainly through cortisol regulation. Individuals who have experienced early-life adversity often have a hyperactive hypothalamicpituitary-adrenal axis and an increased stress response, 42 which is partly caused by decreased hippocampal expression of glucocorticoid receptors and is associated with increased DNA methylation of its promoter 43 in both central nervous tissues and peripheral tissues such as blood or saliva.
44 FKBP5 inhibits glucocorticoid receptor signal transduction and might contribute to the risk of suicidal behaviour; FKBP5 sequence variants are associated with an increased risk of suicidal behaviour, especially in people who have had early-life adversity. 21 Early-life adversity is also associated with epigenetic modifi cation of genes involved in neuronal plasticity, neuronal growth, and neuroprotection. 45, 46 Animal models of early-life adversity show hypermethylation and consequent downregulation of BDNF. 47 Studies of brain tissue from people who completed suicide show that mRNAs encoding BDNF and its receptor TRKB are downregulated in several brain regions including the prefrontal cortex and the hippocampus, and some studies report diff erential methylation of BDNF and TRKB in the brains of people who died by suicide compared with in people who died from other causes. 48, 49 Genome-wide association studies of people with depression or people who have died by suicide and who had early-life adversity have identifi ed methylation changes in genes associated with stress, cognitive processes, and neural plasticity. 45, 46 This evidence supports the hypothesis that early-life adversity mediates suicide risk through long-term epigenetic regulation of gene expression.
Another potential risk factor for suicidal behaviour is infection with the brain-tropic parasite Toxoplasma gondii. 50, 51 In a large sample of women tested for T gondii infection at childbirth and followed up for more than a decade, seropositive women had increased risk of self-directed violence (OR 1·53, 95% CI 1·27-1·85), violent suicide attempt (1·81, 1·13-2·84), and suicide (2·05, 0·78-5·20), with risk of self-directed violence correlated with concentrations of anti-toxoplasma antibodies. 50 One proposed mechanism for this association involves immunological responses to infection, which might alter neurotransmitter activity.
Developmental or mediating risk factors
Distal factors probably act through personality traits and cognitive styles that mediate their association with suicidal behaviour. Although depression and anxiety make strong contributions to the risk of suicidal behaviour throughout life, results of both retrospective and prospective studies suggest that interpersonal confl ict, impulsive aggression, conduct disorder, antisocial behaviour, and alcohol and substance misuse are more salient for suicidal behaviour in adolescents and young adults, whereas harm avoidance and mood disorders become more common with increasing age. 53, 54 Young people who die by suicide often have a high burden of adversity and a history of childhood abuse or neglect. 54 The highest risk for suicidal behaviour across the lifespan exists when a mood disorder that is associated with suicidal ideation co-occurs with other disorders that either increase distress (panic disorder, post-traumatic stress disorder) or decrease restraint (conduct and antisocial disorders, substance misuse). 7 The development of high impulsive-aggressive behaviours and high anxiety traits might also partly explain the relation between early-life adversity and suicide risk, 55 and these traits explain part of the familial aggregation of suicidal behaviour. 33, 56 Early-life adversity causes cognitive defi cits, particularly in problem-solving and memory specifi city, which are contributors to suicidality. 57, 58 It might have an especially important role in suicidal behaviour in adolescent and young adults because adversity is related to earlier age of onset of psychiatric disorder, 59 and because the cognitive eff ects of adversity interact with adolescents' and young adults' incompletely developed prefrontal cortical systems, which in turn increases the likelihood of risk-taking and impulsive behaviour. 60 Individuals with a higher than average cortisol response to stress, 61 a history of suicide ideation, 62 or a fi rst-degree relative who has died by suicide 63 have impaired cognitive functions after social or emotional stressors, as measured by decision making, problem-solving, and executive function. Adolescents who are poor at problem-solving are more likely to experience suicide ideation after a stressful experience than other adolescents, 64 suggesting that altered cognitive patterns might mediate the eff ect of early-life adversity on suicidal behaviour.
Proximal or precipitating risk factors
Proximal risk factors are temporally associated with suicidal behaviours and act as their precipitants. Aside from past suicide attempts, psychopathology is the most important predictor of suicide and strongly associates with other forms of suicidal behaviour. 65, 66 Retrospective, proxy-based interviews with informants, commonly referred to as psychological autopsies, have often been used to investigate the association between psychopathology and suicide, and consistently show that roughly 90% of individuals who die by suicide had an identifi able psychiatric disorder before death. 65 Most individuals with a psychiatric illness do not die by suicide, but some psychiatric illnesses are more strongly linked to suicidal behaviours than others. Major depressive episodes, associated with either major depressive disorder or bipolar disorder, account for at least half of suicide deaths. 67 Among patients with bipolar disorder, mixed state episodes most strongly associate with suicide attempts, with risk increasing according to the amount of time spent in mixed depressive episodes; 67 suicide risk is highest within the fi rst year of illness 68 and associates with feelings of hopelessness. 67 Adults with schizophrenia and other psychotic disorders are also at heightened risk; 69 the main clinical predictors of suicide include presence of depressive symptoms, young age, male sex, education, positive symptoms, and illness insight. 70 Multiple other factors, such as alcohol and drugrelated disorders, are common in people who die by suicide and might exacerbate underlying risk or interact with depression to increase risk of engaging in suicidal behaviours. 66, 71 Other illnesses common in people who die by suicide include eating disorders and personality disorders, particularly cluster B personality disorders such as borderline and antisocial personality disorder, which are characterised by aggressive and impulsive traits. 72 People who die by suicide often have a history of more than one disorder, and in individuals with psychiatric illnesses such as depression, which is associated with suicide ideation, comorbidity with disorders characterised by severe anxiety or agitation or poor impulse control predicts suicidal behaviour. 71, 72 Studies also suggest that people who die by suicide who did not meet criteria for a mental illness were probably aff ected by a psychiatric disorder, but the psychological autopsy protocol failed to detect it. 73 Although psychological autopsies have several limitations because they are retrospective and done by proxy, they are often the only way to identify and describe risk factors that contribute to suicide and generally show strong concordance between independent raters, personal and proxy-informants, and ante-mortem and post-mortem diagnoses. 74 In addition to methodological factors, age, geographic location, and sex largely explain the variability between studies. Younger age at suicide is associated with comorbidity, particularly with cluster B personality pathology and substance misuse disorders. 53, 75 In middleaged people, alcohol and substance misuse, high anxiety, and comorbid major depression disorder are associated with suicide risk, 76, 77 whereas in older people there is a stronger association between suicide and psychopathology, particularly major depressive disorder. 78 Geographic origin is another source of variation, with more people who die by suicide in Europe and the Americas meeting criteria for psychiatric disorders than in those from Asia, 1 where other factors might also contribute to the risk of suicide. In China, rural areas have three-times higher rates of suicide than do urban areas. 79 The easy access to highly lethal pesticides, which are the most common method of suicide in China, might contribute to the high fatality rate of the largely impulsive low-intent suicide attempts that characterise suicide in rural China; increased lethality of suicide attempts might partly explain why, relative to men, women in China have higher rates of suicide death than in other parts of the world. 79 In sum, although several factors explain variation among studies in the strength and characteristics of the association between psychopathology and suicide, almost all individuals who intentionally end their lives, irrespective of whether or not they meet structured criteria for a psychiatric disorder, show evidence of hopelessness, depressed mood, and suicide ideation.
Suicidal states associate with various molecular changes that are detectable both in the periphery, such as blood and saliva, and in the brain (fi gure 3). 21 Among the fi rst to be described was the altered levels of serotonin and serotonin signalling in individuals exhibiting suicidal behaviours. 80 Several studies link disrupted serotonin expression to suicide attempt or suicide, and despite discrete diff erences in serotonin receptor and transporter expression between patients with depression and those who exhibit suicide ideation or suicidal behaviours, 81 it is unclear to what extent altered serotonin signalling in people who die by suicide can be distinguished from changes associated with depression because these two phenotypes often occur together. 82 There is evidence that individuals exhibiting suicidal behaviours have unique serotonin genotype and expression patterns, 83, 84 and low serotonin is associated with personality traits linked to suicidality, such as impulsive aggression. 85 Other neurotransmitters implicated in depression and suicide are glutamate and γ-aminobutyric acid, 86, 87 and treatments targeting the glutamate pathway, such as ketamine, have yielded some promising initial results in the treatment of severe depression and suicide ideation. 88 Aside from neuro transmitters, infl ammatory responses have been linked to suicidal behaviour, with some evidence suggesting that infl ammation linked to suicidality might occur both in the central nervous system and in peripheral tissues, as detected in blood samples. 89 Consistent with the data from studies of early-life adversity, stress response systems might be altered during suicidal states. Substantial alterations of the polyamine system 90 and the hypothalamic-pituitaryadrenal axis 43, 91 have been described in the brains of people who attempt suicide and who die by suicide. Altered responses to stressful social situations might lead to psychopathological disorders and suicidal behaviour, with evidence that suicidality is associated with several changes in the brains of people with suicidal ideation or behaviours. 92 Glial cell function might also be disrupted in people who show suicidal behaviours, 93 where astrocyte-specifi c genes linked to structural integrity are downregulated, 94, 95 and neurotrophic factors such as the BDNF receptor TRKB are expressed diff erently in people who die by suicide and controls. 48 Other proximal risk factors also have a role in risk of suicide, either independently or by interacting with psychopathological disorders (panel 1).
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Interventions to prevent or treat suicidal behaviour Prevention
Several reviews of the effi cacy of diff erent prevention practices have been published. [100] [101] [102] [103] School, workplace, and community-based interventions, and multicomponent primary care interventions, can reduce the incidence of suicide or suicidal behaviour, as can the organisation of and access to care, and reduced access to means of suicide.
School-based interventions reduce the incidence of suicide ideation or suicidal behaviour. The Good Behaviour Game, a teacher-led classroom intervention for children aged 6-7 years, reduced suicide ideation and suicidal behaviour in one of two randomised trials (the other trial was underpowered), 102 and the Signs of Suicide (SOS) programme, which educates students about the relation between mental disorders and suicide, self-identifi cation of depression and suicidal risk, and encourages appropriate help-seeking, also reduced the incidence of suicide attempts. 102 An international cluster randomised trial that compared screening and referral, gatekeeper training (in which strategically positioned individuals are trained to recognise people at risk of suicide and refer them to appropriate services), and a mental health awareness programme similar to the SOS programme showed that only the mental health awareness programme was associated with a lower incidence of serious suicide ideation and suicide attempts. 104 Studies of post-high school suicide prevention similarly showed no eff ect for educational or gatekeeper interventions, but one quasi-experimental study showed that method restriction and mandatory professional assessment of students who exhibit suicidal behaviours reduced the suicide rate.
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A multi-component preventive intervention programme in the US Air Force, including leadership and gatekeeper training, increased access to mental health services, coordination of care for high-risk individuals, and a higher level of confi dentiality for those who disclosed suicidality reduced suicide rates by 35%. 105 Among elderly people, some evidence suggests that interventions to decrease isolation and augment social support through activity groups and telephone outreach might also reduce mortality caused by suicide. 101 A substantial proportion of patients access primary care within 1 month of suicide, but are rarely diagnosed with a mental disorder. 2 Education programmes for primary care doctors targeting identifi cation and treatment of depression can decrease regional suicide rates, particularly in women, but need continued education and additional physician support to improve patient outcomes. [106] [107] [108] In particular, websites for physicians, increasing liaison between physicians and psychiatric facilities, public education campaigns to train key community facilitators in the recognition of depression and suicide risk, and a suicide hotline might all be important aspects of prevention strategies. 109 Collaborative care, in which care for psychiatric disorders is co-located with primary care, provides substantial benefi ts over usual care in outcomes for depression and anxiety, 110 and improves suicide ideation in older patients with depression. 111 Patients recently discharged from psychiatric inpatient units are at very high risk for completed suicide. an enduring inability to cope with the loss; complicated grief and development of suicide ideation or behaviour is more likely in cases of bereavement caused by a violent death such as suicide • Financial or legal diffi culties • Physical illnesses with concurrent depression: respiratory diseases such as chronic obstructive pulmonary disorder and asthma (for death by suicide vs other causes, odds ratio 1·5-2·1), cardiovascular diseases such as coronary heart disease and stroke (1·53-1·54), degenerative diseases such as osteoporosis and multiple sclerosis (2·33-2·54); diff ers by sex, with increased risk for women 96, 97 • Chronic diseases acting independently of mental disorders: infl ammatory bowel disease, migraine (hazard ratio 1·34), 98 and epilepsy (adjusted odds ratio 2·9, when controlling for sociodemographic factors and using sibling controls); 99 in patients with epilepsy, suicidal behaviours can precede onset of seizures or be a sequela of treatment • Sleep disturbances and insomnia: increased risk of suicide ideation or suicidal behaviours can be independent of depression; might be mediated by increased impulsivity, negative cognitive bias, and reward-seeking Through decades of research, Appleby and colleagues have identifi ed factors of mental health services that are associated with increased suicide risk (eg, lack of 24 h crisis care), made recommendations for systems change, and assessed the relation between regional changes in suicide rate and the level of regional implementation of the recommended systems modifi cations. 112 Declining regional suicide rates are related to the extent of care, clear policies for the management of dual diagnosis patients, and multidisciplinary reviews of suicide deaths.
The eff ect of means restriction is estimated on the basis of before-and-after or other types of quasi-experimental designs. Means restriction strategies are guided by the assumption that many suicides are impulsive, and restricting access to lethal methods might forestall a suicidal crisis; even if method substitution takes place, the person will have access to less lethal, potentially non-fatal means of suicide. 113 The eff ect of means restriction on attempting or completing suicide have been assessed in case-control studies and regional comparisons of suicide rates and methods. The rate of suicide by a given method, whether fi rearms, natural gas, car exhaust, paracetamol, substitution of less toxic drugs (eg, selective serotonin reuptake inhibitors vs tricyclic antidepressants), pesticides, or jumping from bridges, is related to the ease of access. 113 Laws that impede access to a method, whether stricter fi rearms control laws, detoxifi cation of domestic gas or car exhaust, limitation of access and use of blister packs for paracetamol, lockboxes for pesticides, or bridge barriers (often combined with a telephone hotline for crisis intervention), reduce suicides by that method, although some method substitution might occur. 113 Brief, individuallevel interventions to encourage safe storage of hazardous items such as pesticides or fi rearms can work, although the eff ect of these interventions on morbidity or mortality has not been recorded.
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Case management and outreach
Panel 2 summarises the key aspects of detecting and treating suicidal behaviour. 114, 115 Maintaining follow-up with people who present to an emergency department after a suicide attempt can reduce repetition of suicide attempt in the following 12 months (overall relative risk 0·83, 95% CI 0·71-0·97; n=5319), 116 as evidenced by two interventions that decreased the suicide rate compared with usual care:
117 a large international study of an emergency department-based intervention that provided follow-up case management and encouragement of adherence resulted in a suicide rate of 0·2% versus 2·2% with usual care (n=1867); and supportive letters sent to patients who had exhibited suicidal behaviors, did not adhere to treatment, and had been discharged from an inpatient unit, decreased the suicide rate within the fi rst 2 years of the intervention (1·8% vs 3·5% with usual care, n=843). Many studies trying to replicate the latter fi ndings using postcards for patients who attempted self-poisoning showed a reduction in the risk of repeated overdose.
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Somatic treatment for suicidal behaviour
Meta-analyses of randomised controlled trials of drug treatment for depression show that antidepressant treatment decreases suicide ideation in individuals aged 25 years and older. 118 Some evidence suggests that selective serotonin reuptake inhibitors result in greater reduction of suicide ideation than either venlafaxine or bupropion. 119, 120 In participants aged 24 years and younger, antidepressant treatment decreases depressive symptoms, but does not always diminish suicide ideation. 118 Antidepressant treatment in people younger than 25 years is associated with a 1-2% risk diff erence in the incidence of suicidal events-ie, new-onset or worsening suicide ideation, or suicide attempts. 121 The US Food and Drug Administration issued a warning in 2004 about the possibility of increased suicidality associated with antidepressants in young people, and several other countries followed. After this warning, rates of diagnosis of depression and prescriptions of antidepressants for young people have declined, 122 and overdoses of psychotropic drugs and suicide in this group have increased. 123 Pharmacoepidemiological studies using data from 26 countries show that sales and prescriptions of selective serotonin reuptake inhibitors are inversely correlated with national and regional suicide rates, including in young people. 124 The larger size and unselected nature of samples used in pharmacoepidemiological studies, which include highrisk patients who typically would be excluded from randomised controlled trials, might explain the discrepancy between the apparent protective eff ect of antidepressants in pharmacoepidemiological studies and increased incidence of suicidal events reported in young people enrolled in clinical trials.
Other drugs used in mood disorders have shown some effi cacy for suicidal behaviour. Observational studies show that lithium content in water is inversely correlated with regional suicide rates, 125 naturalistic treatment studies associate exposure to lithium with a low suicide and suicide attempt rate compared with antiepileptic drugs, 126, 127 and meta-analyses of randomised controlled trials support lithium's protective eff ect against suicide. 128 In 48 randomised controlled trials involving 6674 individuals with unipolar or bipolar depression, lithium was associated with a diminished rate of suicide relative to placebo (OR 0·13, 95% CI 0·03-0·66) and a decreased rate of deliberate self-harm for lithium compared with carbamazepine. 128 Although the exact mechanisms by which lithium decreases suicidal behaviours are unknown, it might act by reducing mood disorder episodes or by decreasing impulsive and aggressive behaviour. 129 There is growing enthusiasm for use of ketamine, a glutamatergic drug used as an anaesthetic, to treat suicidal behaviour. Trials using low doses have shown an antidepressant response within minutes of administration in patients with major depressive disorder or bipolar disorder. 130 Preliminary studies have
shown that single and repeated doses of ketamine can reduce suicide ideation, making it a promising treatment for patients with suicidal behaviours in emergency departments. 88 The main disadvantages of ketamine are its potential for misuse, the transient nature of the response, and cardiac and psychotomimetic side-eff ects.
Other classes of drugs also have antisuicidal eff ects. In the InterSePT trials, clozapine, an atypical antipsychotic used for treatment-refractory schizophrenia, decreased suicide attempts and emergency referrals for suicide ideation compared with olanzapine (hazard ratio 0·76, 95% CI 0·58-0·97) in patients with schizophrenia or schizoaff ective disorder at high risk for suicidal behaviour. 131 Naturalistic studies (observational studies in community or in clinical settings, typically with no control) show that patients treated with clozapine have one-third the incidence of completed and attempted suicide compared with patients treated with other antipsychotics. 132 In addition to drug interventions, electroconvulsive therapy might reduce suicidal behaviour. In an openlabel study of patients with depression at high suicidal risk, more than three-quarters of patients treated with electroconvulsive therapy had no suicidal thoughts or intent after nine sessions, which is consistent with previous studies. 133, 134 Other neuromodulatory treatments might have similar eff ects on suicide ideation. Preliminary evidence suggests that high doses of repetitive transcranial magnetic stimulation applied to the left prefrontal cortex might rapidly decrease suicide ideation.
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Psychotherapeutic interventions for recurrent suicidal behaviour
Most effi cacious treatments for suicidal behaviour share several common elements: use of exploratory interventions to understand the behaviour and interventions to encourage positive, and discourage negative, behaviours; explicitly focusing on suicidal behaviour; having the profi le and manifestations of suicidal behaviours: multidisciplinary interventions strongly based on psychotherapy for chronic suicidal behaviours and more aggressive forms of intervention for acute suicidal behaviours • Elderly patients manifesting acute suicidal behaviours typically require interventions that guarantee safety, such as hospital admission • Internet-based applications to monitor patients after discharge and between appointments can improve patient outcomes, although further study is necessary to show their eff ectiveness • Improved coordination between primary and secondary care and frequent follow-up after discharge probably improve outcomes therapist adopt an active attitude to treatment including problem-solving; planning for coping with suicidal urges; and focusing on emotional and cognitive precursors of suicidal behaviour. 136 Dialectic behaviour therapy is probably the most commonly investigated psychotherapy for recurrent suicidal behaviour. It has mainly been studied in patients with borderline personality disorder; dialectic behaviour therapy promotes belief in one's own ability to succeed, interpersonal eff ectiveness, and emotional regulation, and has repeatedly been shown to reduce the recurrence of suicidal behaviour compared with usual treatment, with more modest diff erences compared with expert community care. 137 Dialectic behaviour therapy is derived from cognitive behaviour therapy, which can also reduce recurrence of suicidal behaviour, with larger eff ects in adults than in adolescents, with individual versus group treatment, and when suicidality is an explicit focus of treatment. 138, 139 The psychodynamically derived mentalisation-based therapy, in which patients are taught how to think about their and other people's actions as the result of underlying thoughts and emotions, thereby improving their ability to understand their own and others' perceptions, is also eff ective in reducing suicidal behaviours according to two trials in adults with borderline personality disorder. 137 For adolescents, a meta-analysis of studies addressing self-harm showed an overall eff ect of treatment compared with usual treatment, with some of the most promising interventions being cognitive behavioural therapy, dialectic behaviour therapy, mentalisation, and family therapy; successful interventions were more likely to have a family component and be off ered as multiple sessions.
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Perspectives
Suicidal behaviours are heterogeneous, both in terms of presentation and treatment, making it diffi cult to provide an all-encompassing model of suicide risk or to suggest a clear treatment formula. Because of the complexity and the breadth of the subject, we present an overview of the present state of knowledge in suicide research. Certain aspects, such as detailed discussions of the psychology of suicide and suicide prevention, have been well described elsewhere. 17, 141 Ongoing advances in suicide research are enriching the clinician's options to manage suicidal patients. Based on clinical trials and natural experiments of drug and psychotherapeutic interventions, improvements in patient identifi cation and treatment, outreach, and method restriction, there is strong evidence that suicide is preventable. Greater sensitivity to the potential for suicidal behaviour, continued improvements in public health policy, and basic and translational research have the potential to contribute to reducing global rates of suicide in the future.
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